Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
CECreative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc. (CELZ)

NASDAQ Capital Market · Currency in USD
$0.74 ▼ -0.03 (-4.39%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.77
Open
$0.75
Day's Range
$0.73 – $0.75
52 Week Range
$0.62 – $6.25
Volume
24,515
Avg. Volume
7,065,961
Market Cap
$1.91M
Beta (5Y Monthly)
1.91
PE Ratio (TTM)
--
EPS (TTM)
-$1.63
Earnings Date
Nov 6, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Creative Medical Technology Holdings, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
4
CEO
Timothy Warbington

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Earnings

Next report: Fri, Nov 6, 2026
EPS estimate -$0.24
DateEst.Actual
Aug 7, 2026-$0.39-$0.41Miss
May 8, 2026-$0.39-$0.38Beat
Mar 20, 2026-$0.37-$0.80Miss
Nov 7, 2025-$0.48-$0.48Beat
Aug 8, 2025-$0.63-$0.48Beat
May 9, 2025-$0.52-$0.83Miss

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on CELZ and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.